Interleukin‐2 promotes pegylated interferon alpha for hepatitis B surface antigen loss: A retrospective pragmatic clinical study at the Fourth Affiliated Hospital of Zhejiang University Medical College-Reference-Cited by-同舟云学术

Interleukin‐2 promotes pegylated interferon alpha for hepatitis B surface antigen loss: A retrospective pragmatic clinical study at the Fourth Affiliated Hospital of Zhejiang University Medical College

Published:2022-11 Issue:6 Volume:5 Page:
ISSN:2398-8835
Container-title:Health Science Reports
language:en
Short-container-title:Health Science Reports

Author:

Qi Wencai¹,Wang Yuming²³^ORCID,Huang Guangyu⁴,Wang Kaifa¹^ORCID

Affiliation:

1. School of Mathematics and Statistics Southwest University Chongqing People's Republic of China

2. Institute for Infectious Diseases, Southwest Hospital Army Medical University Chongqing People's Republic of China

3. Public Health Hospital of Southwest University Chongqing People's Republic of China

4. Department of Infectious Diseases The Fourth Affiliated Hospital Zhejiang University School of Medicine Yiwu Zhejiang People's Republic of China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hsr2.932

Reference26 articles.

1. World Health Organization. Hepatitis. 2022. Accessed January 26 2022. https://www.who.int/health-topics/hepatitis#tab=tab_1

2. Interferon-based treatment is superior to nucleos(t)ide analog in reducing HBV-related hepatocellular carcinoma for chronic hepatitis B patients at high risk

3. Toward a Cure for Hepatitis B Virus Infection: Combination Therapy Involving Viral Suppression and Immune Modulation and Long-term Outcome

4. Roadmap to functional cure of chronic hepatitis B: An expert consensus

5. Sequential combination therapy with interferon, interleukin-2 and therapeutic vaccine in entecavir-suppressed chronic hepatitis B patients: the Endeavor study

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of Recombinant interleukin-2 in the treatment of patients with chronic hepatitis B.;Russian Journal of Infection and Immunity;2024-02-02